Antibody production
Ended Purchase Order Awarded Last action
- Contract number
- 75D30121P10335
- Awardee
-
Promab Biotechnologies, Inc. UEI MNDNCKJR4WL9
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $1,450
Award facts
- Opportunity
-
- 75D30121Q72820 Solicitation number
- Contract value 9% obligated
- $16,630.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Richmond, CA 94804, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$15,180 | |
| Original award | $16,630 |
About this award
The Department of Health and Human Services Centers for Disease Control and Prevention awarded Promab Biotechnologies, Inc. a $16,630.00 firm fixed-price purchase order for antibody production services. This contract had a small business set-aside designation and was performed in Richmond, California, with a completion date of August 6, 2021. Promab Biotechnologies is a minority-owned, Asian-Pacific American-owned, for-profit small business that develops and commercializes recombinant proteins, antibodies, and engineered cell lines. In addition to this contract, Promab has received other federal awards, including a $49,675.00 purchase order from the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute for DNA synthesis and subcloning services, and a sub-award related to NK and macrophage CAR T cell work under a grant prime recipient, SRI International.
Quick answers
Who was awarded contract 75D30121P10335?
75D30121P10335 was awarded to Promab Biotechnologies, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on March 1, 2021.
How much is contract 75D30121P10335 worth?
The government has obligated $1,450 on 75D30121P10335. Its current value, with exercised options, is $16,630.
Was contract 75D30121P10335 competed?
The extent of competition for 75D30121P10335 was competed under sap. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award